{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:12:44Z","timestamp":1788412364529,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1059660"],"award-info":[{"award-number":["APP1059660"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1156072"],"award-info":[{"award-number":["APP1156072"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.euroneuro.2020.01.004","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T08:15:21Z","timestamp":1580112921000},"page":"120-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The effect of combined treatment with SSRIs and renin-angiotensin system (RAS) drugs: A propensity score matched cohort study"],"prefix":"10.1016","volume":"32","author":[{"given":"Ole","family":"K\u00f6hler-Forsberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0479-5379","authenticated-orcid":false,"given":"Liselotte","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6194-1099","authenticated-orcid":false,"given":"Christiane","family":"Gasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8032-6208","authenticated-orcid":false,"given":"S\u00f8ren Dinesen","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.euroneuro.2020.01.004_bib0001","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav. Res."},{"issue":"1","key":"10.1016\/j.euroneuro.2020.01.004_bib0002","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0004867417721654","article-title":"Blockade of the angiotensin system improves mental health domain of quality of life: a meta-analysis of randomized clinical trials","volume":"52","author":"Brownstein","year":"2018","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2020.01.004_bib0003","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"issue":"1","key":"10.1016\/j.euroneuro.2020.01.004_bib0004","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/acps.12576","article-title":"Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels","volume":"134","author":"Dahl","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2020.01.004_bib0005","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Assoc."},{"issue":"6","key":"10.1016\/j.euroneuro.2020.01.004_bib0006","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10741-017-9637-0","article-title":"Effect of renin-angiotensin system inhibitors on mortality in heart failure with preserved ejection fraction: a meta-analysis of observational cohort and randomized controlled studies","volume":"22","author":"Fukuta","year":"2017","journal-title":"Heart Fail. Rev."},{"issue":"5","key":"10.1016\/j.euroneuro.2020.01.004_bib0007","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/pds.1223","article-title":"Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the Netherlands","volume":"15","author":"Gardarsdottir","year":"2006","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"7","key":"10.1016\/j.euroneuro.2020.01.004_bib0008","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1403494811399958","article-title":"The Danish register of causes of death","volume":"39","author":"Helweg-Larsen","year":"2011","journal-title":"Scand. J. Publ. Health"},{"issue":"7","key":"10.1016\/j.euroneuro.2020.01.004_bib0009","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1403494810394715","article-title":"Danish education registers","volume":"39","author":"Jensen","year":"2011","journal-title":"Scand. J. Publ. Health"},{"issue":"1","key":"10.1016\/j.euroneuro.2020.01.004_bib0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/acps.12957","article-title":"New drug candidates for depression \u2013 a nationwide population-based study","volume":"139","author":"Kessing","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2020.01.004_bib0011","first-page":"1","article-title":"The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder","author":"Kidnapillai","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2020.01.004_bib0012","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The danish national prescription registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand. J. Publ. Health"},{"issue":"5","key":"10.1016\/j.euroneuro.2020.01.004_bib0013","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies","volume":"135","author":"Kohler","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"8","key":"10.1016\/j.euroneuro.2020.01.004_bib0014","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1176\/appi.ajp.2016.15040463","article-title":"The effect of concomitant treatment with SSRIs and statins: a population-based study","volume":"173","author":"Kohler","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.euroneuro.2020.01.004_bib0015","doi-asserted-by":"crossref","first-page":"e00338","DOI":"10.1002\/brb3.338","article-title":"Inflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes","volume":"5","author":"Kohler","year":"2015","journal-title":"Brain Behav."},{"issue":"2","key":"10.1016\/j.euroneuro.2020.01.004_bib0016","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/acps.12671","article-title":"Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study","volume":"135","author":"Kohler","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.euroneuro.2020.01.004_bib0017","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40263-017-0422-3","article-title":"Do Statins Have Antidepressant Effects?","volume":"31","author":"Kohler-Forsberg","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2020.01.004_bib0018","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jad.2018.12.110","article-title":"Statin treatment and the risk of depression","volume":"246","author":"Kohler-Forsberg","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.euroneuro.2020.01.004_bib0019","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/acps.13016","article-title":"Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials","volume":"139","author":"Kohler-Forsberg","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"issue":"7","key":"10.1016\/j.euroneuro.2020.01.004_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish national patient register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand. J. Publ. Health"},{"issue":"7","key":"10.1016\/j.euroneuro.2020.01.004_bib0021","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1403494810395825","article-title":"The Danish psychiatric central research register","volume":"39","author":"Mors","year":"2011","journal-title":"Scand. J. Publ. Health"},{"issue":"7","key":"10.1016\/j.euroneuro.2020.01.004_bib0022","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/1403494810390728","article-title":"Register-based studies of mental disorders","volume":"39","author":"Munk-Jorgensen","year":"2011","journal-title":"Scand. J. Publ. Health"},{"issue":"3","key":"10.1016\/j.euroneuro.2020.01.004_bib0023","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jclinepi.2005.07.015","article-title":"Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery","volume":"59","author":"Nuttall","year":"2006","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.euroneuro.2020.01.004_bib0024","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jad.2016.02.029","article-title":"Depression is a risk factor for incident coronary heart disease in women: an 18-year longitudinal study","volume":"196","author":"O'Neil","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.euroneuro.2020.01.004_bib0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pharmthera.2006.10.001","article-title":"Type 1 angiotensin receptor pharmacology: signaling beyond G proteins","volume":"113","author":"Oro","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.euroneuro.2020.01.004_bib0026","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish civil registration system","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand. J. Publ. Health"},{"issue":"1","key":"10.1016\/j.euroneuro.2020.01.004_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2010.10.001","article-title":"Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications","volume":"36","author":"Saavedra","year":"2011","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.euroneuro.2020.01.004_bib0028","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/joim.12197","article-title":"Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs","volume":"275","author":"Sturmer","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.euroneuro.2020.01.004_bib0029","doi-asserted-by":"crossref","first-page":"h4984","DOI":"10.1136\/bmj.h4984","article-title":"Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study","volume":"351","author":"Tinetti","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.euroneuro.2020.01.004_bib0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2020.01.004_bib0031","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-017-0916-3","article-title":"The renin-angiotensin system: a possible new target for depression","volume":"15","author":"Vian","year":"2017","journal-title":"BMC Med."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20300079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20300079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:54:36Z","timestamp":1760378076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X20300079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":31,"alternative-id":["S0924977X20300079"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.01.004","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of combined treatment with SSRIs and renin-angiotensin system (RAS) drugs: A propensity score matched cohort study","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}